Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.24 USD | -2.05% | -5.07% | -47.89% |
May. 21 | JPMorgan Adjusts Teladoc Price Target to $16 From $19, Maintains Neutral Rating | MT |
Apr. 29 | Truist Securities Cuts Teladoc's Price Target to $15 From $17, Maintains Hold Rating | MT |
Business Summary
Number of employees: 5,208
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Teledoc Health Intergrated Care
56.4
%
| 1,374 | 57.1 % | 1,469 | 56.4 % | +6.91% |
BetterHelp
43.6
%
| 1,020 | 42.4 % | 1,134 | 43.6 % | +11.18% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
86.0
%
| 2,101 | 87.3 % | 2,238 | 86.0 % | +6.50% |
International
14.0
%
| 306 | 12.7 % | 365 | 14.0 % | +19.31% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mala Murthy
CEO | Chief Executive Officer | 60 | 19-06-23 |
Jeff Nadler
CTO | Chief Tech/Sci/R&D Officer | - | 11-01-31 |
Nikolaos Nanis
CTO | Chief Tech/Sci/R&D Officer | - | - |
Yulun Wang
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael Waters
COO | Chief Operating Officer | 51 | 22-07-24 |
Chief Tech/Sci/R&D Officer | - | 22-02-24 | |
Patrick Feeley
IRC | Investor Relations Contact | - | - |
Kelly M. Bliss
PRN | Corporate Officer/Principal | - | 17-10-31 |
Saranya Loehrer
PRN | Corporate Officer/Principal | - | 22-09-11 |
Adam Vandervoort
LAW | General Counsel | 49 | 15-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Snow
CHM | Chairman | 69 | 14-01-31 |
Sandra Fenwick
BRD | Director/Board Member | 73 | 20-11-18 |
David Shedlarz
BRD | Director/Board Member | 75 | 16-09-18 |
Tom McKinley
BRD | Director/Board Member | 72 | 09-10-31 |
Kenneth Paulus
BRD | Director/Board Member | 64 | 17-01-31 |
Mark Smith
BRD | Director/Board Member | 72 | 18-10-14 |
J. Evans
BRD | Director/Board Member | 47 | 23-09-19 |
Director/Board Member | 60 | 20-02-20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 169,588,171 | 168,259,832 ( 99.22 %) | 0 | 99.22 % |
Company contact information
Teladoc Health, Inc.
2 Manhattanville Road Suite 203
10577, Purchase
+203 635 2002
http://www.teladochealth.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.54% | 1.95B | |
+78.57% | 584M | |
+11.22% | 485M | |
-70.98% | 128M | |
-28.06% | 91.48M |
- Stock Market
- Equities
- TDOC Stock
- Company Teladoc Health, Inc.